Last reviewed · How we verify

NCT04892771: Pied-REM

Post-healing Follow-up Study in People With Remission of a Diabetic Foot Ulcer

Completed Last updated 24 January 2022
What this trial tests

trial in Diabetic Foot in 129 participants. Completed in 21 December 2021.

Timeline
20 May 2021
Primary endpoint
21 December 2021
21 December 2021

Quick facts

Lead sponsorCentre Hospitalier Sud Francilien
StatusCompleted
Study typeOBSERVATIONAL
Enrollment129
Start date20 May 2021
Primary completion21 December 2021
Estimated completion21 December 2021
Sites1 location across France

Conditions studied

Sponsor

Centre Hospitalier Sud Francilien

Who can join

18 and older, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the benefit of multidisciplinary specific follow-up of patients with a healed diabetic foot ulcer at the rate of two annual consultation on wound recurrence.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Post-healing follow-up study of patients in remission for diabetic foot ulcers Pied-REM study.
    Bouly M, Laborne FX, Tourte C, Henry E, et al · · 2022 · cited 5× · PMID 35587931 · DOI 10.1371/journal.pone.0268242
  2. The Post-Healing Follow-Up of Diabetic Foot Ulcers by a Multidisciplinary Team to Reduce Their Recurrence: An Observational Retrospective Study.
    Bouly M, Laborne FX, Tourte C, Henry E, et al · · 2025 · PMID 40725667 · DOI 10.3390/jcm14144975

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Centre Hospitalier Sud Francilien trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04892771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing